Beta Bionics, Inc. (BBNX) Free Cash Flow
Beta Bionics, Inc. (BBNX) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2022-12-31 | -$60.98M |
| 2023-12-31 | -$32.85M |
| 2024-12-31 | -$51.67M |
| 2025-12-31 | -$56.22M |
How BBNX compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| RLMD | Relmada Therapeutics Inc. | -$45.79M |
| ACRS | Aclaris Therapeutics Inc. | -$47.22M |
| AQST | Aquestive Therapeutics Inc. | -$52.99M |
| PLSE | Pulse Biosciences Inc | -$54.46M |
| VTGN | Vistagen Therapeutics Inc. | -$66.44M |
These are five companies in the same sector as BBNX with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Beta Bionics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("BBNX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BBNX | $19.72 | +0.92% | 0.99M |
| 3 | ||||
| 4 | ||||
| 5 |